Cerity Partners
VNDA icon

Cerity Partners’s Vanda Pharmaceuticals VNDA Stock Holding History

Cerity Partners’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$722K Buy
117,977
+49,574
+72% +$324K ﹤0.01% 2202
2026
Q1 		$473K Buy
68,403
+38,111
+126% +$294K ﹤0.01% 2329
2025
Q4 		$267K Sell
30,292
-807
-3% -$4.44K ﹤0.01% 2472
2025
Q3 		$155K Buy
31,099
+16,431
+112% +$76.1K ﹤0.01% 2557
2025
Q2 		$69.2K Buy
+14,668
New +$64.1K ﹤0.01% 2524

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Cerity Partners's VNDA Position: Q2 2026 in Review

Cerity Partners increased its Vanda Pharmaceuticals (VNDA) stake by 72% in Q2 2026, buying an estimated $324K and bringing the position to 117,977 shares worth $722K. The position accounts for ﹤0.01% of the portfolio, ranked #2202.

Cerity Partners first reported a position in VNDA in Q2 2025 and has held it in 5 quarters since. 158 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Cerity Partners held 117,977 shares of Vanda Pharmaceuticals worth $722K as of Q2 2026.
  • Cerity Partners bought 49,574 Vanda Pharmaceuticals shares in Q2 2026, an estimated $324K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2202 holding.
  • Cerity Partners first reported a position in Vanda Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 158 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.